PATENT CLAIM ANALYSIS

Application Number: 15950683
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "221000"]

Abstract:
Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs), compositions comprising the compounds, and methods of using the compounds and compositions.

Claim (Index 72):
A method of treating a central nervous disorder (CNS), the method comprising the step of administering to a subject in need thereof, an effective amount of a compound of  claim 63 , thereby treating the disorder.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15315363', '15301697', '14916292', '15714013', '15820194']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957962037666247
- 35 USC 102 Novelty (BERT): 0.5425564576831117
- Combined Prediction Score: 0.7704722291582735
- Mean Citation Score: 379.91734400000007
- Max Citation Score: 459.65045
- Similarity Product: 223.92066810675857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test